These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 19432557)

  • 21. Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro.
    Pucko E; Ostrowski R; Matyja E
    Folia Neuropathol; 2019; 57(3):239-248. PubMed ID: 31588710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential.
    Cozza G; Girardi C; Ranchio A; Lolli G; Sarno S; Orzeszko A; Kazimierczuk Z; Battistutta R; Ruzzene M; Pinna LA
    Cell Mol Life Sci; 2014 Aug; 71(16):3173-85. PubMed ID: 24442476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
    Sarno S; de Moliner E; Ruzzene M; Pagano MA; Battistutta R; Bain J; Fabbro D; Schoepfer J; Elliott M; Furet P; Meggio F; Zanotti G; Pinna LA
    Biochem J; 2003 Sep; 374(Pt 3):639-46. PubMed ID: 12816539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.
    Raaf J; Klopffleisch K; Issinger OG; Niefind K
    J Mol Biol; 2008 Mar; 377(1):1-8. PubMed ID: 18242640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase CK2 is implicated in early steps of the differentiation of pre-adipocytes into adipocytes.
    Wilhelm N; Kostelnik K; Götz C; Montenarh M
    Mol Cell Biochem; 2012 Jun; 365(1-2):37-45. PubMed ID: 22270543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
    López-Ramos M; Prudent R; Moucadel V; Sautel CF; Barette C; Lafanechère L; Mouawad L; Grierson D; Schmidt F; Florent JC; Filippakopoulos P; Bullock AN; Knapp S; Reiser JB; Cochet C
    FASEB J; 2010 Sep; 24(9):3171-85. PubMed ID: 20400536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity.
    Łukowska-Chojnacka E; Wińska P; Wielechowska M; Poprzeczko M; Bretner M
    Bioorg Med Chem; 2016 Feb; 24(4):735-41. PubMed ID: 26778657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase CK2 regulates metal toxicity in neuronal cells.
    Zaman MS; Johnson AJ; Bobek G; Kueh S; Kersaitis C; Bailey TD; Buskila Y; Wu MJ
    Metallomics; 2016 Jan; 8(1):82-90. PubMed ID: 26623569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight.
    Lolli G; Cozza G; Mazzorana M; Tibaldi E; Cesaro L; Donella-Deana A; Meggio F; Venerando A; Franchin C; Sarno S; Battistutta R; Pinna LA
    Biochemistry; 2012 Aug; 51(31):6097-107. PubMed ID: 22794353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Features and potentials of ATP-site directed CK2 inhibitors.
    Sarno S; Salvi M; Battistutta R; Zanotti G; Pinna LA
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):263-70. PubMed ID: 16198160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethyl 2-(benzylidene)-7-methyl-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-6-carboxylate analogues as a new scaffold for protein kinase casein kinase 2 inhibitor.
    Jin CH; Jun KY; Lee E; Kim S; Kwon Y; Kim K; Na Y
    Bioorg Med Chem; 2014 Sep; 22(17):4553-65. PubMed ID: 25131958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resorufin: a lead for a new protein kinase CK2 inhibitor.
    Sandholt IS; Olsen BB; Guerra B; Issinger OG
    Anticancer Drugs; 2009 Apr; 20(4):238-48. PubMed ID: 19177021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library.
    Guerra B; Hochscherf J; Jensen NB; Issinger OG
    Mol Cell Biochem; 2015 Aug; 406(1-2):151-61. PubMed ID: 25963666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DMAT, an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks.
    Schneider CC; Hessenauer A; Götz C; Montenarh M
    Oncol Rep; 2009 Jun; 21(6):1593-7. PubMed ID: 19424641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
    Raaf J; Brunstein E; Issinger OG; Niefind K
    Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward the rational design of protein kinase casein kinase-2 inhibitors.
    Sarno S; Moro S; Meggio F; Zagotto G; Dal Ben D; Ghisellini P; Battistutta R; Zanotti G; Pinna LA
    Pharmacol Ther; 2002; 93(2-3):159-68. PubMed ID: 12191608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity.
    Cozza G; Zanin S; Sarno S; Costa E; Girardi C; Ribaudo G; Salvi M; Zagotto G; Ruzzene M; Pinna LA
    Biochem J; 2015 Nov; 471(3):415-30. PubMed ID: 26349539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
    Sekiguchi Y; Nakaniwa T; Kinoshita T; Nakanishi I; Kitaura K; Hirasawa A; Tsujimoto G; Tada T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2920-3. PubMed ID: 19414254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening.
    Li C; Zhang X; Zhang N; Zhou Y; Sun G; Zhao L; Zhong R
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31935979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.